Evaluation of Win 49,596, a novel steroidal androgen receptor antagonist, in animal models of prostate cancer.
Juniewicz, P E
Evaluation of Win 49,596, a novel steroidal androgen receptor antagonist, in animal models of prostate cancer. [electronic resource] - The Prostate 1991 - 105-15 p. digital
Publication Type: Comparative Study; Journal Article
0270-4137
10.1002/pros.2990180203 doi
Administration, Oral
Androgen Antagonists--therapeutic use
Animals
Antineoplastic Agents--therapeutic use
Drug Administration Schedule
Flutamide--therapeutic use
Male
Orchiectomy
Pregnanes--administration & dosage
Prostatic Neoplasms--drug therapy
Pyrazoles--administration & dosage
Rats
Rats, Inbred Strains
Evaluation of Win 49,596, a novel steroidal androgen receptor antagonist, in animal models of prostate cancer. [electronic resource] - The Prostate 1991 - 105-15 p. digital
Publication Type: Comparative Study; Journal Article
0270-4137
10.1002/pros.2990180203 doi
Administration, Oral
Androgen Antagonists--therapeutic use
Animals
Antineoplastic Agents--therapeutic use
Drug Administration Schedule
Flutamide--therapeutic use
Male
Orchiectomy
Pregnanes--administration & dosage
Prostatic Neoplasms--drug therapy
Pyrazoles--administration & dosage
Rats
Rats, Inbred Strains